Developmental brain programs and biomarker activation in Alzheimer's disease
Clicks: 6
ID: 327486
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
1.5
/100
6 views
5 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #123 of 130 articles by views in Brain communications
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 130 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Abstract Recent studies show that serum glial fibrillary acidic protein (GFAP) is highest in healthy infancy and early childhood and then declines steadily with age, while plasma tau protein phosphorylated at position 217 is strikingly elevated in healthy newborns and can exceed values observed in Alzheimer’s disease. Additional evidence indicates that soluble phosphorylated tau forms are not specific to Alzheimer’s disease, as increased tau protein phosphorylated-217 has been reported in MAPT R406W carriers without amyloid pathology and in Niemann-Pick disease type C, where plasma tau protein phosphorylated-217 is associated with disease progression and lysosomal enlargement. These observations invite a broader review of biomarker biology across development, physiological remodeling, and neurodegeneration. We hypothesize that, at least in part, increases of GFAP, tau protein phosphorylated-217 and related biomarkers in Alzheimer’s disease reflect a chronic attempt of the aging brain to reactivate multicellular programs that are physiologically engaged during development, repair, and circuit refinement. In this framework, biomarker elevation does not necessarily indicate that the reactive program is intrinsically toxic. Rather, persistent elevation may index the duration and intensity of unresolved metabolic, inflammatory, vascular, proteostatic, mitochondrial or infectious stressors that keep repair and homeostatic systems engaged until their compensatory capacity is exceeded. Protein precipitation is therefore positioned as a downstream consequence of persistent stress, chronic compensatory activation, increased protein turnover, secretion or processing, and impaired clearance or proteostasis. This Review summarizes the developmental biomarker evidence, examines alternative interpretations, and discusses therapeutic implications focused on upstream stressors and failed resolution rather than biomarker lowering alone.
| Reference Key |
openalex_W7207739503
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Lorenzo Pini, Monica Margoni, Massimo Filippi, Bruno P. Imbimbo |
| Journal | Brain communications |
| Year | 2026 |
| DOI |
10.1093/braincomms/fcag337
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.